SCHEMBL35211758

SCHEMBL35211758

CC(=O)N1C[C@H](C)n2nc3c(Cl)c(Cl)c(O)cc3c2C1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL35212567 0.85 SMN1; SMN2 (0.36) —
SCHEMBL35212021 0.79 GAA (0.31) —
SCHEMBL35212572 0.76 SCN9A (0.31) —
SCHEMBL34466268 0.76 SCN9A (0.31) —
SCHEMBL35212367 0.73 CCR1 (0.32) —
SCHEMBL35211354 0.73 ALDH1A1 (0.34) —
SCHEMBL35212137 0.73 CCR1 (0.32) —
SCHEMBL35212570 0.73 SMN1; SMN2 (0.31) —
SCHEMBL35211270 0.73 CFD (0.31) —
SCHEMBL35211430 0.73 CFD (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260125383-A1 INDAZOLE INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF VENTUS THERAPEUTICS U.S., INC. (US) 2026-05-07 — — US disclosed
Send feedback